• Abstract
    Deadline Extended : July 20, 2023

  • Notification
    Acceptance: August 4, 2023

Abstract Submission

Abstract Submission Process

  • 1Sign Up

    If you are already signed-up on this website, you can use the account for your abstract submission.

  • 2SubmissionandConfirmation

    After your abstract submission, a confirmation letter will be sent to you via e-mail.

  • 3My Page

    To review or modify your submitted abstracts, visit 'My Page'.

  • 4Acceptance Notification

    An acceptance notification will be sent to you via e-mail.

Important Notes:

  • The Presenting Author of the abstract must be one of the authors listed in the abstract. The abstract submission should be done by the first author of the abstract.
  • All presenting authors must have registered and paid to attend the conference by September 4, 2023.
  • Abstracts must be submitted in English.
  • Abstracts may not be withdrawal or updated following the notification of acceptance.

Abstract Category

Abstracts can be submitted for presentation at the conference in one of the following categories:

  • Oral Presentation: Free Paper Presentation or Oral Poster Presentation
  • OR
  • Poster Exhibition (no oral presentation requested)

Guidelines for Abstract Submission

Please adhere to the following formatting guidelines when submitting abstracts for the conference. 

  • Abstract title: must not exceed 20 words (First letter of each word in uppercase, except for articles, prepositions, and conjunctions).
  • Abstract text: must not exceed 300 words (excluding the Title, Authors, and Affiliations).
  • An Acceptable Structure of an abstract must consist of the following components:
  • Background/Aim: A statement of the hypothesis or research question.
  • Methods: An explanation of the study design and experimental methods used.
  • Results:
    • A concise summary of the major findings of the experiment or study.
    • Sufficient data must be provided to permit evaluation by the reviewers and public reading the abstract.
    • Statements such as "The data will be discussed" are not acceptable.
  • Conclusion(s): Summary of the overall findings and the importance of the study.
  • Graphics and Tables can be submitted as part of an abstract. The maximum file size of each graphic/tables is 500 KB.
  • Author names and affiliations:
    Up to 15 authors and affiliations may be included on each abstract. All authors must have consented to the abstract submission.
    Do not reference institution names, locations, or funding sources in the abstract.
  • Presenting authors are responsible for proofreading before submission. No edits will be allowed in submitted abstracts for typing, spelling, or grammatical errors.

Suggested Topics for Abstract Submission are:

  • Hepatitis B: Basic and Translational Research
  • Hepatitis B: Clinical Aspects
  • Hepatitis B: Diagnostics and Biomarkers
  • Hepatitis B: Current Treatment
  • Hepatitis B: New Therapies and Trials
  • Hepatitis C: Basic and Translational Research
  • Hepatitis C: Clinical Aspects: Non-Therapy
  • Hepatitis C: Clinical Aspect: Therapy
  • Hepatitis D: Basic and Translational Research
  • Hepatitis D: Clinical Aspects
  • Hepatitis A/E: Basic and Translational Research
  • Hepatitis A/E: Clinical Aspects
  • Alcoholic Liver Disease
  • Liver Cancer: Basic and Translational Research
  • Liver Cancer: Treatment
  • Liver Cancer: Non-Therapeutic Aspects
  • Liver Cirrhosis and Portal Hypertension
  • Others

Notification of Acceptance

  • Presenting Authors/Corresponding Author will be notified of their acceptance status via email. Presenting Authors must inform any co-author(s) of acceptance.
  • The Organizing Committee reserves the right to accept or decline any submissions and to select the presentation format.

Abstract Modification or Withdrawal

  • Presenting Authors may modify or withdraw the submitted abstract at My Page prior to the submission deadline.
  • Following receiving a notification of acceptance via email, any abstracts cannot be modified or withdrawn.